ExodusPoint Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$172K	–	1464
2025 Q1	$172K	Buy	+20,000	New	+$189K	﹤0.01%	1314
2024 Q4	–	Sell	-127,270	Closed	-$723K	–	1521
2024 Q3	$723K	Buy	+127,270	New	+$734K	﹤0.01%	1073
2023 Q4	–	Sell	-10,131	Closed	-$66K	–	1469
2023 Q3	$66K	Sell	10,131 -65,898	-87%	-$525K	﹤0.01%	1605
2023 Q2	$618K	Sell	76,029 -20,556	-21%	-$176K	0.01%	1281
2023 Q1	$828K	Sell	96,585 -40,532	-30%	-$405K	0.01%	1201
2022 Q4	$1.27M	Buy	137,117 +84,639	+161%	+$904K	0.02%	850
2022 Q3	$542K	Sell	52,478 -125,635	-71%	-$1.33M	0.01%	1343
2022 Q2	$1.78M	Buy	178,113 +152,189	+587%	+$1.44M	0.02%	830
2022 Q1	$319K	Buy	+25,924	New	+$319K	﹤0.01%	1733
2021 Q4	–	Sell	-35,342	Closed	-$634K	–	2154
2021 Q3	$634K	Buy	+35,342	New	+$703K	0.01%	1259
2021 Q2	–	Sell	-25,007	Closed	-$374K	–	2332
2021 Q1	$374K	Buy	+25,007	New	+$273K	0.01%	1534
2019 Q2	–	Sell	-16,200	Closed	-$49K	–	1095
2019 Q1	$49K	Buy	+16,200	New	+$38.7K	﹤0.01%	637